Mancini Anthony
Mancini Anthony, SR, reported a transaction classified as exercise at Revolution Medicines, Inc. involving 2310.000000 shares for an estimated $77662.20. Reported holdings after the transaction were 42075.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 26, 2026
- Filing date
- Oct 28, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RVMD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-436459 Common Stock
- Transaction date
- Oct 26, 2026 Filed Oct 28, 2026, 10:00 PM · 2d delay
- Shares
- 2,310 sh $33.62 per share
- Estimated value
- $77.6k Computed from shares × price
- Holdings after
- 42,075 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See Remarks
- F1
Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
- F2
Includes 39,575 restricted stock units.
- F3
Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the…
0 other transactions
0 recent txs